Patent · US Active

Hemagglutinin-binding peptide

US12351652B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

PeptiDream Inc. · JP

Inventors

Keiichi Masuya · Bottmingen, CH
Masaki Ohuchi · Kawasaki, JP

Key dates

Filing date	Feb 17, 2020
Grant date	Jul 8, 2025
Priority date	—
Expiry date	Oct 16, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

[Problem to be solved] To provide a compound having markedly higher antiviral activity than iHA 100, an intermediate for producing the compound, and a medical drug, or the like, containing the high-activity compound above. [Solution] The invention relates to a hemagglutinin-binding peptide, a pharmaceutically acceptable salts, or a solvate thereof, the hemagglutinin-binding peptide being: (1) a polypeptide comprising the amino acid sequence represented by SEQ ID NO: 1 or 2: Trp-Thr-MeGly-Asp-MePhe-MePhe-Ala-MeAla-His-Tyr-Thr-Val-hydPro-Ala-Cys (SEQ ID NO: 1), Trp-Thr-MeGly-Asp-MePhe-MePhe-Ala-MeAla-His-Tyr-Thr-Val-hydPro-Ala-Cys-Lys (SEQ ID NO: 2), or the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.